Total Payments
$19,639
2024 Payments
$2,497
Companies
40
Transactions
547
Medicare Patients
2,112
Medicare Billing
$646,179
Payment Breakdown by Category
Food & Beverage$13,515 (68.8%)
Research$3,091 (15.7%)
Other$2,100 (10.7%)
Travel$665.25 (3.4%)
Education$268.03 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,515 | 531 | 68.8% |
| Unspecified | $3,091 | 7 | 15.7% |
| Honoraria | $2,100 | 1 | 10.7% |
| Travel and Lodging | $665.25 | 3 | 3.4% |
| Education | $268.03 | 5 | 1.4% |
Payments by Type
General
$16,548
540 transactions
Research
$3,091
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BioCryst Pharmaceuticals, Inc. | $3,009 | 9 | $0 (2019) |
| Lupin Inc. | $2,500 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $2,034 | 59 | $0 (2024) |
| GENZYME CORPORATION | $1,892 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,885 | 67 | $0 (2024) |
| CSL Behring | $1,821 | 89 | $0 (2024) |
| PFIZER INC. | $918.05 | 47 | $0 (2024) |
| Genentech USA, Inc. | $616.94 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $598.38 | 14 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $544.26 | 32 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,497 | 75 | GENZYME CORPORATION ($539.36) |
| 2023 | $2,587 | 75 | GlaxoSmithKline, LLC. ($624.88) |
| 2022 | $1,958 | 72 | GlaxoSmithKline, LLC. ($393.20) |
| 2021 | $1,712 | 65 | AstraZeneca Pharmaceuticals LP ($317.92) |
| 2020 | $1,012 | 54 | CSL Behring ($279.66) |
| 2019 | $4,652 | 80 | BioCryst Pharmaceuticals, Inc. ($3,009) |
| 2018 | $3,920 | 65 | Lupin Inc. ($2,500) |
| 2017 | $1,302 | 61 | Teva Pharmaceuticals USA, Inc. ($421.76) |
All Payment Transactions
547 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $85.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.70 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Immunology and Neurology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Food and Beverage | In-kind items and services | $135.38 | General |
| Category: Immunology | ||||||
| 11/06/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.65 | General |
| Category: Immunology | ||||||
| 10/10/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/02/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/26/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $72.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 08/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.60 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $2,500 | 1 |
| A PHASE 3, 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP BAYESIAN | GlaxoSmithKline, LLC. | $590.67 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 458 | 5,660 | $270,113 | $121,487 |
| 2022 | 13 | 499 | 6,600 | $327,380 | $149,152 |
| 2021 | 14 | 626 | 8,591 | $404,103 | $183,170 |
| 2020 | 12 | 529 | 8,412 | $426,567 | $192,371 |
Total Patients
2,112
Total Services
29,263
Medicare Billing
$646,179
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 17 | 2,460 | $147,600 | $74,638 | 50.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 193 | $24,125 | $11,889 | 49.3% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 34 | 905 | $14,480 | $9,563 | 66.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 100 | $27,500 | $8,259 | 30.0% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 22 | 113 | $8,475 | $5,365 | 63.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 60 | 368 | $14,720 | $2,775 | 18.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 17 | 981 | $6,867 | $2,563 | 37.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 58 | 116 | $11,600 | $1,986 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,400 | $1,730 | 39.3% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 15 | 238 | $2,856 | $1,258 | 44.0% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 20 | 138 | $4,830 | $934.70 | 19.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 12 | 12 | $1,860 | $284.68 | 15.3% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 17 | 20 | $800.00 | $242.46 | 30.3% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 16 | 3,330 | $199,800 | $99,611 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 224 | $28,106 | $13,596 | 48.4% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 35 | 807 | $12,912 | $8,784 | 68.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 85 | $23,375 | $7,407 | 31.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 16 | 112 | $8,400 | $6,101 | 72.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 22 | 1,006 | $7,042 | $2,951 | 41.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 64 | 397 | $15,920 | $2,874 | 18.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 75 | 147 | $14,700 | $2,604 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,395 | $1,835 | 41.7% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 15 | 270 | $3,240 | $1,658 | 51.2% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 25 | 164 | $5,740 | $964.96 | 16.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 16 | 18 | $2,790 | $469.60 | 16.8% |
About Dr. Patricia Gerber, M.D
Dr. Patricia Gerber, M.D is a Allergy & Immunology healthcare provider based in North Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023097532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patricia Gerber, M.D has received a total of $19,639 in payments from pharmaceutical and medical device companies, with $2,497 received in 2024. These payments were reported across 547 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($13,515).
As a Medicare-enrolled provider, Gerber has provided services to 2,112 Medicare beneficiaries, totaling 29,263 services with total Medicare billing of $646,179. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location North Charleston, SC
- Active Since 01/12/2006
- Last Updated 11/17/2015
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1023097532
Products in Payments
- DUPIXENT (Biological) $2,526
- ADVAIR (Drug) $2,500
- Haegarda (Biological) $1,101
- NUCALA (Biological) $921.30
- TEZSPIRE (Biological) $916.09
- Hizentra (Biological) $693.67
- FASENRA (Drug) $625.25
- Xolair (Biological) $592.69
- PANZYGA (Biological) $496.67
- CINQAIR (Drug) $437.26
- FASENRA (Biological) $288.59
- CUTAQUIG (Biological) $270.94
- Xhance (Drug) $260.23
- EUCRISA (Drug) $243.84
- CUVITRU (Biological) $221.72
- TAKHZYRO (Biological) $220.19
- AREXVY (Drug) $217.36
- ORLADEYO (Drug) $199.47
- ACTIMMUNE (Drug) $178.81
- CINRYZE (Drug) $178.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in North Charleston
Dr. Allen Kaplan, M.d.m.d, M.D.M.D
Allergy & Immunology — Payments: $319,198
Allergy & Immunology $319,198
Dr. Ned Rupp, M.d, M.D
Allergy & Immunology — Payments: $187,402
Allergy & Immunology $187,402
Dr. John Ramey, Md, MD
Allergy & Immunology — Payments: $181,754
Allergy & Immunology $181,754
Dr. Frederick Schaffer, M.d, M.D
Allergy & Immunology — Payments: $55.00
Allergy & Immunology $55.00
Dr. Allan Lieberman, M.d, M.D
Allergy & Immunology — Payments: $15.19
Allergy & Immunology $15.19
Dr. Albert Finn, M.d, M.D
Allergy & Immunology
Allergy & Immunology